子宫输卵管造影前预先使用丁溴东莨菪碱对不孕女性近端输卵管梗阻诊断的影响:一项随机双盲对照试验
在宋卡纳加林医院不孕门诊开展随机双盲对照试验,146例不孕女性在子宫输卵管造影前30分钟随机口服丁溴东莨菪碱20mg或安慰剂。丁溴东莨菪碱组近端输卵管梗阻率显著低于安慰剂组(8.6% vs 22.5%,P=0.04),假性梗阻率也较低(20% vs 69.2%)。结论认为造影前使用丁溴东莨菪碱可降低近端输卵管梗阻诊断率及假性梗阻率。
要点
- 造影前30分钟口服丁溴东莨菪碱20mg可降低近端输卵管梗阻诊断率。
- 丁溴东莨菪碱组近端梗阻率8.6%,显著低于安慰剂组的22.5%。
- 二次确认后丁溴东莨菪碱组假性梗阻率20%,低于安慰剂组的69.2%。
核心结论
- 子宫输卵管造影前预先使用丁溴东莨菪碱可降低近端输卵管梗阻的诊断率及假性梗阻率。
研究设计与样本
- 随机双盲对照试验(加拿大任务组分类I级),于2016年5月1日至2017年3月31日在宋卡纳加林医院不孕门诊纳入146例需行子宫输卵管造影的不孕女性。
- 参与者随机口服丁溴东莨菪碱20mg或安慰剂,均在造影前30分钟给药。
- 若发现近端输卵管梗阻,参与者在6个月内接受第二次确认性子宫输卵管造影或腹腔镜染色通液术。
主要发现
- 丁溴东莨菪碱组70例中6例发现近端输卵管梗阻,安慰剂组71例中16例发现近端输卵管梗阻。
- 丁溴东莨菪碱组近端输卵管梗阻率显著低于安慰剂组(8.6% vs 22.5%;P=0.04;绝对差值13.9%;95%CI 0.02-0.26;相对危险度0.38;95%CI 0.16-0.92)。
- 完成第二次子宫输卵管造影或腹腔镜者共22例,丁溴东莨菪碱组假性梗阻率为20%(1/6),安慰剂组为69.2%(9/16)。
临床怎么用
- 作者认为子宫输卵管造影前预先使用丁溴东莨菪碱可降低近端输卵管梗阻诊断率及假性梗阻率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To assess the effect of hyoscine-N-butylbromide (HBB) as premedication on the rate of proximal tubal obstruction during hysterosalpingography (HSG). DESIGN: A randomized, double-blind controlled trial (Canadian Task Force classification I). SETTING: The Infertility Clinic of Songklanagarind Hospital. PATIENTS: One hundred and forty-six infertile women indicated for HSG investigation. INTERVENTIONS: Between May 1, 2016, and March 31, 2017, patients were assigned at random to receive either oral HBB 20 mg or placebo 30 minutes before the HSG procedure. If proximal tubal obstruction was found, participants were be assigned to undergo a second confirming HSG or laparoscopy with chromopertubation within 6 months. MEASUREMENTS AND MAIN RESULTS: The primary outcome was the rate of proximal tubal obstruction. The secondary outcome was the false-positive result of proximal tubal occlusion from HSG. Proximal tubal obstruction was found in 6 of 70 patients in the HBB group and in 16 of 71 in the placebo group. The rate of proximal tubal obstruction was significantly lower in the HBB group than in the placebo group (8.6% vs 22.5%; p = .04; absolute difference, 13.9%; 95% confidence interval [CI], 0.02-0.26; relative risk, 0.38; 95% CI, 0.16-0.92). After the second HSG or laparoscopy was performed (n = 22), the rate of false occlusion was 20% (1 of 6 patients) in the HBB group, compared with 69.2% (9 of 16 patients) in the placebo group. CONCLUSION: Premedication with HBB before HSG can reduce the rate of diagnosis of proximal tubal obstruction and false occlusion.
引用
- Jitchanwichai A, Soonthornpun K. Effect of Premedication Hyoscine-N-Butylbromide before Hysterosalpingography for Diagnosis of Proximal Tubal Obstruction in Infertile Women: A Randomized Double-Blind Controlled Trial. J Minim Invasive Gynecol. 2018. PMID: 29702271. doi:10.1016/j.jmig.2018.03.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。